×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
💹
Economics
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Economics
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Clinical: KarXT+EC Phase 3 (NCT07011732): Enhanced Formulation for AD
clinical
3,402 words
KG: ent-clin-0fe90d7d
2026-03-26
kind:clinical-trial
section:clinical-trials
state:published
Contents
KarXT+EC Phase 3 (NCT07011732): Enhanced Formulation for AD Agitation
Knowledge Graph
Related Hypotheses (16)
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.78
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.76
Phase-Separated Organelle Targeting
Score: 0.73
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.72
Stress Granule Phase Separation Modulators
Score: 0.72
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.72
Cryptic Exon Silencing Restoration
Score: 0.70
Cross-Seeding Prevention Strategy
Score: 0.69
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.68
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.68
RNA Granule Nucleation Site Modulation
Score: 0.66
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.64
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.61
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.59
Show 11 more
Related Analyses (9)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Show 4 more
Related Experiments (1)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)